IAS 2011: Where we go from here

By on .

Dr. Anthony Fauci speaks out on treatment as prevention, pre-exposure prophylaxis and the way forward

More details were fleshed out on several compelling studies finding antiretroviral treatment is effective in preventing HIV infection  – two pre-exposure prophylaxis studies as well as a large study (HPTN 052) looking at treatment of HIV infected persons in stable discordant partnerships showed significant protection for the uninfected person.

Science Speaks addressed these new studies and other topics Monday evening with Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, Dr. Anthony Fauci at the 2011 International AIDS Society meeting in Rome.

Given the exciting trial results that have come out recently in support of treatment as prevention, do you think there should be a reconsideration of federal funding allocation to treatment in particular for global AIDS?

You said in your talk earlier that the tension between prevention and treatment is over – but there seems to be continued tension in both the activist and scientific community between treatment as prevention and PrEP? … Especially in developing world settings, where as you know 9 million people await treatment.  If you were making the call about the deployment of resources in SSA, what decisions would you make regarding treatment as prevention and PrEP?

As you know – Science Speaks is a project of the Center for Global Health Policy at the Infectious Diseases Society of America – an organization of more than 10,000 ID docs, about 40 percent of whom engage in HIV care and treatment.  How can we utilize our constituency to meet the implementation challenge you articulated in Science Magazine?

New infections in Uganda are not decreasing, and as you’ve read in recent reports some are blaming this on focusing on treatment rather than prevention and calling for a reversion back to ABC. What are your thoughts on this?

In the presentation by Dr. Robin Shattock at the IAS 2011 meeting here in Rome, he mentioned the need for studies looking at a combination of prevention interventions. In the near term what combination of interventions makes the most sense to study in your opinion?

3 thoughts on “IAS 2011: Where we go from here

  1. Pingback: IAS 2011 News Roundup - Day 2 #HIV #AIDS #IAS2011 | Sayen CroWolf

  2. Pingback: International Health Policies » IHPN#127

  3. Pingback: IHPN#127 | International Health Policies

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.